# Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

> **NCT04709172** · PHASE4 · COMPLETED · sponsor: **Meiji Pharma Spain S.A.** · enrollment: 20 (actual)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **DRUG:** Cefditoren pivoxil 400mg

## Key facts

- **NCT ID:** NCT04709172
- **Lead sponsor:** Meiji Pharma Spain S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-05
- **Primary completion:** 2021-08-15
- **Final completion:** 2021-08-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04709172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04709172, "Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04709172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*